![](/img/cover-not-exists.png)
Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat(R) fixed-dose combination for chronic obstructive pulmonary disease patients in Italy
Selya-Hammer, C., Gonzalez-Rojas Guix, N., Baldwin, M., Ternouth, A., Miravitlles, M., Rutten-van Mo lken, M., Goosens, L. M. A., Buyukkaramikli, N., Acciai, V.Language:
english
Journal:
Therapeutic Advances in Respiratory Disease
DOI:
10.1177/1753465816657272
Date:
July, 2016
File:
PDF, 1001 KB
english, 2016